Effects of Lipiflow on Meibography, LLT, Tear Osmolarity and OSDI | ASCRS
Presentation
Effects of Lipiflow on Meibography, LLT, Tear Osmolarity and OSDI
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-304: Highlights From the Military Refractive Surgery Safety & Standards Symposium held in San Diego in January, 2019
Presenter: Shamis Fallah, DO
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

This presentation reports interim results from an ongoing prospective study of the effects of Lipiflow on Lipid Layer Thickness (LLT), Tear Osmolarity, and subjective dry-eye symptoms (OSDI). Our understanding of Meibomian Gland Dysfunction suggests that treatment with Lipiflow should tend to increase LLT, decrease tear osmolarity, and improve subjective symptoms. However, so far we have found no significant changes in LLT or tear osmolarity, and only modest improvements in OSDI.
View More Presentations from SYM-304

This presentation is from the session "SYM-304: Highlights From the Military Refractive Surgery Safety & Standards Symposium held in San Diego in January, 2019" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.